IMPROVEMENTS IN PATIENT-REPORTED OUTCOMES AMONG PATIENTS WITH RESOLUTION OF ENTHESITIS AND/OR DACTYLITIS: POST HOC ANALYSES FROM THE KEEPSAKE 1 AND 2 TRIALS OF RISANKIZUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS

被引：0
|
作者：
Kwatra, S. [1 ]
Khattri, S. [2 ]
Amin, A. [3 ]
Liu, R. [4 ]
Padilla, B. [4 ]
Soliman, A. M. [4 ]
Kaplan, B. [4 ]
Mcgonagle, D. [5 ,6 ]
机构：
[1] Johns Hopkins Univ, Dept Dermatol, Baltimore, MD USA
[2] Mt Sinai, Dept Dermatol, New York, NY USA
[3] Northwestern Med Dermatol, Dermatol, Chicago, IL USA
[4] AbbVie, Dept Immunol, N Chicago, IL USA
[5] Univ Washington, Div Rheumatol, Seattle, WA USA
[6] Univ Leeds, Leeds Teaching Hosp NHS Trust, Leeds, W Yorkshire, England
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Spondyloarthritis; Enthesitis; Pain;
D O I：
10.1136/annrheumdis-2023-eular.2790
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0957
引用
收藏
页码：1696 / 1697
页数：2
相关论文
共 50 条
  • [21] Maintenance of Patient-Reported Outcomes in Baricitinib-Treated Patients with Moderate-to-Severe Active Rheumatoid Arthritis: Post Hoc Analyses from Two Phase 3 Trials
    Sholter, Dalton
    Wu, Jianmin
    Jia, Bochao
    Zhang, Hong
    Griffing, Kirstin
    Birt, Julie
    Reis, Paulo Jorge Simoes
    Liu, Huaxiang
    Bingham, Clifton O., III
    RHEUMATOLOGY AND THERAPY, 2022, 9 (02) : 541 - 553
  • [22] GUSELKUMAB MAINTAINS RESOLUTION OF DACTYLITIS AND ENTHESITIS IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: RESULTS THROUGH 2 YEARS FROM A PHASE 3 STUDY
    Rahman, P.
    Mcinnes, I.
    Deodhar, A.
    Schett, G.
    Mease, P. J.
    Shawi, M.
    Cua, D.
    Sherlock, J.
    Kollmeier, A.
    Xu, X. L.
    Jiang, Y.
    Sheng, S.
    Ritchlin, C. T.
    Mcgonagle, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 826 - 827
  • [23] Improvements in Patient-Reported Outcomes After Treatment With Deucravacitinib in Patients With Psoriatic Arthritis: Results From a Randomized Phase 2 Trial
    Strand, Vibeke
    Gossec, Laure
    Coates, Laura C.
    Ogdie, Alexis
    Choi, Jiyoon
    Becker, Brandon
    Zhuo, Joe
    Lehman, Thomas
    Nowak, Miroslawa
    Elegbe, Ayanbola
    Mease, Philip J.
    Deodhar, Atul
    ARTHRITIS CARE & RESEARCH, 2024, 76 (08) : 1139 - 1148
  • [24] Ixekizumab Treatment Significantly Improves Enthesitis and Dactylitis in Patients with Active Psoriatic Arthritis: Results from Two Phase 3 Trials
    Gladman, Dafna D.
    Orbai, Ana-Maria
    Gallo, Gaia
    Birt, Julie
    Rathmann, Suchitrita
    Marzo-Ortega, Helena
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [25] Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies
    Strand, Vibeke
    de Vlam, Kurt
    Covarrubias-Cobos, Jose A.
    Mease, Philip J.
    Gladman, Dafna D.
    Hendrikx, Thijs
    Kudlacz, Elizabeth
    Graham, Daniela
    Wu, Joseph
    Cappelleri, Joseph C.
    Hsu, Ming-Ann
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [26] EFFECTS OF TREATMENT WITH RISANKIZUMAB ON REDUCING PAIN AND INFLAMMATION IN PATIENTS WITH PSORIATIC ARTHRITIS: AN ANALYSIS OF THE KEEPSAKE-1 AND-2 TRIALS
    Ostor, A.
    Kwatra, S.
    Nduaka, C.
    Patel, M.
    Soliman, A. M.
    Barcomb, L.
    Xue, Z.
    Photowala, H.
    Papp, K.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1579 - 1579
  • [27] Effects of treatment with risankizumab on reducing pain and inflammation in patients with psoriatic arthritis: An analysis of the KEEPsAKE-1 and-2 trials
    Ostor, Andrew
    Kwatra, Shawn
    Nduaka, Chudi
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB49 - AB49
  • [28] Guselkumab (TREMFYA®) Maintains Resolution of Dactylitis and Enthesitis in Patients with Active Psoriatic Arthritis: Results Through 2 Years from a Phase 3 Study
    Rahman, Proton
    McInnes, Iain
    Deodhar, Atul
    Schett, Georg
    Mease, Philip
    Shawi, May
    Cua, Daniel
    Sherlock, Jonathan
    Kollmeier, Alexa
    Xu, Xie
    Jiang, Yusang
    Sheng, Shihong
    Ritchlin, Christopher
    McGonagle, Dennis
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2757 - 2760
  • [29] Relationships Between Psoriatic Arthritis Disease Activity Score and Patient-Reported Outcomes in Patients with Psoriatic Arthritis: Post Hoc Analysis of Two Phase 3 Studies
    Coates, Laura
    Bushmakin, Andrew
    FitzGerald, Oliver
    Gladman, Dafna
    Fallon, Lara
    Cappelleri, Joseph
    Hsu, Ming-Ann
    Helliwell, Philip
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [30] Improvements in Manifestations of Active Psoriatic Arthritis With Risankizumab Treatment After Intolerance or Inadequate Response to Prior Biologic Therapy: Subgroup Analyses From the KEEPsAKE 2 Trial
    Strober, Bruce
    Kivitz, Alan
    Ostor, Andrew
    Padilla, Byron
    Yue, Cuiyong
    Photowala, Huzefa
    Merola, Joseph F.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2023, 89 (03) : AB179 - AB179
12345